Endogenous and Exogenous Opioids in Pain.
暂无分享,去创建一个
Michael R Bruchas | M. Bruchas | Daniel C. Castro | Grégory Scherrer | G. Corder | G. Scherrer | Gregory Corder | Daniel C Castro
[1] H. Fields,et al. Circuitry linking opioid-sensitive nociceptive modulatory systems in periaqueductal gray and spinal cord with rostral ventromedial medulla , 1992, Neuroscience.
[2] N. Maidment,et al. Constitutively Active Mu Opioid Receptors Mediate the Enhanced Conditioned Aversive Effect of Naloxone in Morphine-Dependent Mice , 2006, Neuropsychopharmacology.
[3] R. Al-Hasani,et al. Pain and Poppies: The Good, the Bad, and the Ugly of Opioid Analgesics , 2015, The Journal of Neuroscience.
[4] T. Yamamoto,et al. Antagonism of ORLI receptor produces an algesic effect in the rat formalin test. , 2001, Neuroreport.
[5] Henry Lin,et al. Structure-based discovery of opioid analgesics with reduced side effects , 2016, Nature.
[6] V. Durmaz,et al. A nontoxic pain killer designed by modeling of pathological receptor conformations , 2017, Science.
[7] Leonard J. Paulozzi,et al. Vital Signs: Overdoses of Prescription Opioid Pain Relievers and Other Drugs Among Women — United States, 1999–2010 , 2013, MMWR. Morbidity and mortality weekly report.
[8] M. Bruchas,et al. Sciatic Nerve Ligation-Induced Proliferation of Spinal Cord Astrocytes Is Mediated by κ Opioid Activation of p38 Mitogen-Activated Protein Kinase , 2007, The Journal of Neuroscience.
[9] Sara R. Jones,et al. Biased agonists of the kappa opioid receptor suppress pain and itch without causing sedation or dysphoria , 2016, Science Signaling.
[10] C. Inturrisi. Clinical Pharmacology of Opioids for Pain , 2002, The Clinical journal of pain.
[11] Kevin T. Beier,et al. A Brainstem-Spinal Cord Inhibitory Circuit for Mechanical Pain Modulation by GABA and Enkephalins , 2017, Neuron.
[12] R. Gainetdinov,et al. Enhanced morphine analgesia in mice lacking beta-arrestin 2. , 1999, Science.
[13] M. Bruchas,et al. Long-Acting κ Opioid Antagonists Disrupt Receptor Signaling And Produce Noncompetitive Effects By Activating C-Jun N-Terminal Kinase* , 2007, Journal of Biological Chemistry.
[14] L. Pardo,et al. Crystal structure of the μ-opioid receptor bound to a morphinan antagonist , 2012, Nature.
[15] Alipasha Vaziri,et al. A Guide to Emerging Technologies for Large-Scale and Whole-Brain Optical Imaging of Neuronal Activity. , 2018, Annual review of neuroscience.
[16] P. Law,et al. delta-Opioid receptor immunoreactivity: distribution in brainstem and spinal cord, and relationship to biogenic amines and enkephalin , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[17] M. Caron,et al. Neuropathic Pain Activates the Endogenous κ Opioid System in Mouse Spinal Cord and Induces Opioid Receptor Tolerance , 2004, The Journal of Neuroscience.
[18] J. Kauer,et al. Constitutive activation of kappa opioid receptors at ventral tegmental area inhibitory synapses following acute stress , 2017, eLife.
[19] R. Luján,et al. New insights into the therapeutic potential of Girk channels , 2014, Trends in Neurosciences.
[20] E. E. Bagley,et al. Endogenous opioids regulate moment-to-moment neuronal communication and excitability , 2017, Nature Communications.
[21] Lee S. Simon. RELIEVING PAIN IN AMERICA: A BLUEPRINT FOR TRANSFORMING PREVENTION, CARE, EDUCATION, AND RESEARCH , 2012, Military medicine.
[22] Laxmaiah Manchikanti,et al. Opioid epidemic in the United States. , 2012, Pain physician.
[23] C. Vaughan,et al. Chronic morphine reduces the readily releasable pool of GABA, a presynaptic mechanism of opioid tolerance , 2017, The Journal of physiology.
[24] M. von Zastrow,et al. Regulation of µ-Opioid Receptors: Desensitization, Phosphorylation, Internalization, and Tolerance , 2013, Pharmacological Reviews.
[25] R. Al-Hasani,et al. Molecular mechanisms of opioid receptor-dependent signaling and behavior. , 2011, Anesthesiology.
[26] Katja Wiech,et al. Deconstructing the sensation of pain: The influence of cognitive processes on pain perception , 2016, Science.
[27] J. Levine,et al. Fentanyl Induces Rapid Onset Hyperalgesic Priming: Type I at Peripheral and Type II at Central Nociceptor Terminals , 2018, The Journal of Neuroscience.
[28] T. Yaksh,et al. The Emerging Role of Spinal Dynorphin in Chronic Pain: A Therapeutic Perspective. , 2016, Annual review of pharmacology and toxicology.
[29] Viviana Gradinaru,et al. Viral Strategies for Targeting the Central and Peripheral Nervous Systems. , 2018, Annual review of neuroscience.
[30] M. Stoffel,et al. G-Protein-Gated Potassium Channels Containing Kir3.2 and Kir3.3 Subunits Mediate the Acute Inhibitory Effects of Opioids on Locus Ceruleus Neurons , 2002, The Journal of Neuroscience.
[31] M. Bruchas,et al. Nociceptin/Orphanin FQ Receptor Structure, Signaling, Ligands, Functions, and Interactions with Opioid Systems , 2016, Pharmacological Reviews.
[32] T. Kenakin,et al. Inverse, protean, and ligand‐selective agonism: matters of receptor conformation , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[33] Michael Mousseau,et al. Blocking microglial pannexin-1 channels alleviates morphine withdrawal in rodents , 2017, Nature Medicine.
[34] T. Vanderah,et al. Underlying mechanisms of pronociceptive consequences of prolonged morphine exposure , 2005, Biopolymers.
[35] E. Navratilova,et al. Behavioral and neurochemical analysis of ongoing bone cancer pain in rats , 2015, Pain.
[36] Julia C. Lemos,et al. The Dysphoric Component of Stress Is Encoded by Activation of the Dynorphin κ-Opioid System , 2008, The Journal of Neuroscience.
[37] H. Loh,et al. Distribution and targeting of a mu-opioid receptor (MOR1) in brain and spinal cord , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[38] C. Woolf,et al. Inflammation-induced decrease in voluntary wheel running in mice: A nonreflexive test for evaluating inflammatory pain and analgesia , 2012, PAIN®.
[39] Marc G Caron,et al. Enhanced Rewarding Properties of Morphine, but not Cocaine, in βarrestin-2 Knock-Out Mice , 2003, The Journal of Neuroscience.
[40] M. Bruchas,et al. Stress-Induced p38 Mitogen-Activated Protein Kinase Activation Mediates κ-Opioid-Dependent Dysphoria , 2007, The Journal of Neuroscience.
[41] M. von Zastrow,et al. GPCR signaling along the endocytic pathway. , 2014, Current opinion in cell biology.
[42] R. Gereau,et al. Central serotonergic neurons are differentially required for opioid analgesia but not for morphine tolerance or morphine reward , 2007, Proceedings of the National Academy of Sciences.
[43] Elyssa B. Margolis,et al. Understanding opioid reward , 2015, Trends in Neurosciences.
[44] T. Vanderah. Delta and Kappa Opioid Receptors as Suitable Drug Targets for Pain , 2010, The Clinical journal of pain.
[45] Xiaoping Zhou,et al. Identifying local and descending inputs for primary sensory neurons. , 2015, The Journal of clinical investigation.
[46] W. Maixner,et al. μ-Opioid receptor 6-transmembrane isoform: A potential therapeutic target for new effective opioids , 2015, Progress in Neuro-psychopharmacology and Biological Psychiatry.
[47] M. Bruchas,et al. Ligand-directed c-Jun N-terminal kinase activation disrupts opioid receptor signaling , 2010, Proceedings of the National Academy of Sciences.
[48] R. Stevens,et al. Structure of the human k-opioid receptor in complex with JDTic , 2012 .
[49] G. Pasternak. Faculty Opinions recommendation of Loss of μ opioid receptor signaling in nociceptors, but not microglia, abrogates morphine tolerance without disrupting analgesia. , 2017 .
[50] I. Vetter,et al. The μ opioid agonist morphine modulates potentiation of capsaicin-evoked TRPV1 responses through a cyclic AMP-dependent protein kinase A pathway , 2006, Molecular pain.
[51] J. Violin,et al. Biased mu‐opioid receptor ligands: a promising new generation of pain therapeutics , 2017, Current opinion in pharmacology.
[52] T. Kaneko,et al. Dynorphin Acts as a Neuromodulator to Inhibit Itch in the Dorsal Horn of the Spinal Cord , 2014, Neuron.
[53] B. Morgan,et al. Enkephalin. Synthesis of two pentapeptides isolated from porcine brain with receptor-mediated opiate agonist activity. , 1976, Journal of the Chemical Society. Perkin transactions 1.
[54] P. Phillips,et al. Peroxiredoxin 6 mediates Gαi protein-coupled receptor inactivation by cJun kinase , 2017, Nature Communications.
[55] Michael M. Halassa,et al. Toward an Integrative Theory of Thalamic Function. , 2018, Annual review of neuroscience.
[56] A. Craig. A new view of pain as a homeostatic emotion , 2003, Trends in Neurosciences.
[57] D. Filliol,et al. Genetic ablation of delta opioid receptors in nociceptive sensory neurons increases chronic pain and abolishes opioid analgesia , 2011, PAIN.
[58] S. Linnarsson,et al. Unbiased classification of sensory neuron types by large-scale single-cell RNA sequencing , 2014, Nature Neuroscience.
[59] Masahiko Watanabe,et al. A quantitative study of neurochemically defined populations of inhibitory interneurons in the superficial dorsal horn of the mouse spinal cord , 2017, Neuroscience.
[60] F. Bloom,et al. β-Endorphin: cellular localization, electrophysiological and behavioral effects , 1979 .
[61] L. Bohn,et al. Seeking (and Finding) Biased Ligands of the Kappa Opioid Receptor. , 2017, ACS medicinal chemistry letters.
[62] Alison L. Barth,et al. Generation of a KOR‐Cre knockin mouse strain to study cells involved in kappa opioid signaling , 2016, Genesis.
[63] J. Pintar,et al. Developmental Expression of the μ, κ, and δ Opioid Receptor mRNAs in Mouse , 1998, The Journal of Neuroscience.
[64] R. Dolle,et al. Peripherally restricted opioid agonists as novel analgesic agents. , 2004, Current pharmaceutical design.
[65] G. Scherrer,et al. Delta Opioid Receptor Expression and Function in Primary Afferent Somatosensory Neurons. , 2017, Handbook of experimental pharmacology.
[66] David Julius,et al. Cellular and Molecular Mechanisms of Pain , 2009, Cell.
[67] F. Medzihradsky,et al. Receptor-mediated stimulation of brain GTPase by opiates in normal and dependent rats. , 1984, Biochemical and biophysical research communications.
[68] D. Filliol,et al. Mu Opioid Receptors on Primary Afferent Nav1.8 Neurons Contribute to Opiate-Induced Analgesia: Insight from Conditional Knockout Mice , 2013, PloS one.
[69] P. Fuchs,et al. Selective regulation of pain affect following activation of the opioid anterior cingulate cortex system , 2006, Experimental Neurology.
[70] H. Loh,et al. Immunofluorescent identification of a delta (delta)-opioid receptor on primary afferent nerve terminals. , 1993, Neuroreport.
[71] V. Pickel,et al. Ultrastructural Immunocytochemical Localization of μ-Opioid Receptors in Rat Nucleus Accumbens: Extrasynaptic Plasmalemmal Distribution and Association with Leu5-Enkephalin , 1996, The Journal of Neuroscience.
[72] H. Akil,et al. Opioid receptor‐like (ORL1) receptor distribution in the rat central nervous system: Comparison of ORL1 receptor mRNA expression with 125I‐[14Tyr]‐orphanin FQ binding , 1999, The Journal of comparative neurology.
[73] A. Basbaum,et al. Delta Opioid Receptors Presynaptically Regulate Cutaneous Mechanosensory Neuron Input to the Spinal Cord Dorsal Horn , 2014, Neuron.
[74] J. Sandkühler,et al. Erasure of a Spinal Memory Trace of Pain by a Brief, High-dose , 2022 .
[75] D. Dodick,et al. Kappa opioid receptor antagonists: A possible new class of therapeutics for migraine prevention , 2017, Cephalalgia : an international journal of headache.
[76] Jonathan R. Tomshine,et al. Conformational biosensors reveal GPCR signalling from endosomes , 2013, Nature.
[77] G. Koob,et al. Chronic CRF1 receptor blockade reduces heroin intake escalation and dependence‐induced hyperalgesia , 2015, Addiction biology.
[78] H. Fields,et al. Endogenous Opioid Activity in the Anterior Cingulate Cortex Is Required for Relief of Pain , 2015, The Journal of Neuroscience.
[79] L. Bohn,et al. Functional Selectivity at the μ-Opioid Receptor: Implications for Understanding Opioid Analgesia and Tolerance , 2011, Pharmacological Reviews.
[80] Wei Chen,et al. Differential regulation and properties of MAPKs , 2007, Oncogene.
[81] G. Pasternak,et al. Broad-spectrum analgesic efficacy of IBNtxA is mediated by exon 11-associated splice variants of the mu-opioid receptor gene , 2014, Pain.
[82] M. Nooh,et al. Barcoding of GPCR trafficking and signaling through the various trafficking roadmaps by compartmentalized signaling networks. , 2017, Cellular signalling.
[83] C. Chavkin. Dynorphin–Still an Extraordinarily Potent Opioid Peptide , 2013, Molecular Pharmacology.
[84] S. Schulz,et al. Targeting multiple opioid receptors – improved analgesics with reduced side effects? , 2018, British journal of pharmacology.
[85] V. Pickel,et al. Ultrastructural relationship between N-methyl-d-aspartate-NR1 receptor subunit and mu-opioid receptor in the mouse central nucleus of the amygdala , 2009, Neuroscience.
[86] Aaron M. Beedle,et al. ORL1 receptor–mediated internalization of N-type calcium channels , 2006, Nature Neuroscience.
[87] J. Manzanares,et al. Involvement of the dynorphin/KOR system on the nociceptive, emotional and cognitive manifestations of joint pain in mice , 2017, Neuropharmacology.
[88] P. Prather,et al. Chronic exposure to mu-opioid agonists produces constitutive activation of mu-opioid receptors in direct proportion to the efficacy of the agonist used for pretreatment. , 2001, Molecular pharmacology.
[89] T. Vanderah,et al. Tonic Descending Facilitation from the Rostral Ventromedial Medulla Mediates Opioid-Induced Abnormal Pain and Antinociceptive Tolerance , 2001, The Journal of Neuroscience.
[90] K. Berridge,et al. Opioid Hedonic Hotspot in Nucleus Accumbens Shell: Mu, Delta, and Kappa Maps for Enhancement of Sweetness “Liking” and “Wanting” , 2014, The Journal of Neuroscience.
[91] J. Zubieta,et al. Placebo effects on human μ-opioid activity during pain , 2007, Proceedings of the National Academy of Sciences.
[92] N. Ling,et al. beta-Lipotropin as a prohormone for the morphinomimetic peptides endorphins and enkephalins. , 1976, Proceedings of the National Academy of Sciences of the United States of America.
[93] H. Akil,et al. Mu, delta, and kappa opioid receptor mRNA expression in the rat CNS: An in situ hybridization study , 1994, The Journal of comparative neurology.
[94] Qingmin Chen,et al. Pronociceptive actions of dynorphin via bradykinin receptors , 2008, Neuroscience Letters.
[95] C. Büchel,et al. Mechanisms of placebo analgesia: rACC recruitment of a subcortical antinociceptive network , 2006, Pain.
[96] L. Iversen,et al. Enkephalin and opiate narcotics increase cyclic GMP accumulation in slices of rat neostriatum , 1976, Nature.
[97] H. Fields,et al. Morphine microinjected into the periaqueductal gray has differential effects on 3 classes of medullary neurons , 1986, Brain Research.
[98] R. Adan,et al. Morphine Withdrawal Enhances Constitutive μ-Opioid Receptor Activity in the Ventral Tegmental Area , 2012, The Journal of Neuroscience.
[99] S. Mitra,et al. Peripheral opioid receptor agonists for analgesia: a comprehensive review. , 2011, Journal of opioid management.
[100] J. Gybels,et al. Morphine differentially affects the sensory and affective pain ratings in neurogenic and idiopathic forms of pain , 1991, Pain.
[101] M. Olmstead,et al. Neurobiology of Disease Microglia Disrupt Mesolimbic Reward Circuitry in Chronic Pain , 2015 .
[102] Sung Han,et al. Elucidating an Affective Pain Circuit that Creates a Threat Memory , 2015, Cell.
[103] J Lötsch,et al. Differential Opioid Action on Sensory and Affective Cerebral Pain Processing , 2008, Clinical pharmacology and therapeutics.
[104] Bryan L. Roth,et al. Structure of the Nociceptin/Orphanin FQ Receptor in Complex with a Peptide Mimetic , 2012, Nature.
[105] F. Bloom,et al. beta-endorphin: cellular localization, electrophysiological and behavioral effects. , 1978, Advances in biochemical psychopharmacology.
[106] Xin-Qiu Yao,et al. Dynamic Coupling and Allosteric Networks in the α Subunit of Heterotrimeric G Proteins* , 2015, The Journal of Biological Chemistry.
[107] M. Olmstead,et al. Changes in morphine reward in a model of neuropathic pain , 2013, Behavioural pharmacology.
[108] A Thomas McLellan,et al. Opioid Abuse in Chronic Pain--Misconceptions and Mitigation Strategies. , 2016, The New England journal of medicine.
[109] H. Fields,et al. Pain relief produces negative reinforcement through activation of mesolimbic reward–valuation circuitry , 2012, Proceedings of the National Academy of Sciences.
[110] George L. Wilcox,et al. Peripheral mechanisms of pain and analgesia , 2009, Brain Research Reviews.
[111] P. Schwartzkroin,et al. Dynorphin opioids present in dentate granule cells may function as retrograde inhibitory neurotransmitters , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[112] B. Zou,et al. Knock-In Mice with NOP-eGFP Receptors Identify Receptor Cellular and Regional Localization , 2015, The Journal of Neuroscience.
[113] T. Hales,et al. - Arrestin 2 and c-Src Regulate the Constitutive Activity and Recycling of Opioid Receptors in Dorsal Root Ganglion Neurons , 2007 .
[114] J. Streicher,et al. Peripherally Acting μ-Opioid Receptor Antagonists for the Treatment of Opioid-Related Side Effects: Mechanism of Action and Clinical Implications , 2017, Journal of pharmacy practice.
[115] F. Simonin,et al. Opioid-induced hyperalgesia: Cellular and molecular mechanisms , 2016, Neuroscience.
[116] P. Lu,et al. The persistence of a long-term negative affective state following the induction of either acute or chronic pain , 2008, PAIN.
[117] S. W. Emmons,et al. Neural Circuits of Sexual Behavior in Caenorhabditis elegans. , 2018, Annual review of neuroscience.
[118] G. Pasternak,et al. μ and δ opioid synergy between the periaqueductal gray and the rostro-ventral medulla , 1994, Brain Research.
[119] Nathan A Baertsch,et al. The Dynamic Basis of Respiratory Rhythm Generation: One Breath at a Time. , 2018, Annual review of neuroscience.
[120] A. Basbaum,et al. Functional Divergence of Delta and Mu Opioid Receptor Organization in CNS Pain Circuits , 2018, Neuron.
[121] Long-chuan Yu,et al. Involvement of ORL1 receptor and ERK kinase in the orphanin FQ-induced nociception in the nucleus accumbens of rats , 2008, Regulatory Peptides.
[122] S. Aicher,et al. μ-Opioid Receptors Often Colocalize with the Substance P Receptor (NK1) in the Trigeminal Dorsal Horn , 2000, The Journal of Neuroscience.
[123] M. Bruchas,et al. Kappa Opioid Receptor Activation of p38 MAPK Is GRK3- and Arrestin-dependent in Neurons and Astrocytes* , 2006, Journal of Biological Chemistry.
[124] Thomas E. Nichols,et al. Placebo Effects Mediated by Endogenous Opioid Activity on μ-Opioid Receptors , 2005, The Journal of Neuroscience.
[125] Julia C. Lemos,et al. Selective p38α MAPK Deletion in Serotonergic Neurons Produces Stress Resilience in Models of Depression and Addiction , 2011, Neuron.
[126] D. Price,et al. A psychophysical analysis of morphine analgesia , 1985, Pain.
[127] Nicole A. Crowley,et al. Distinct Subpopulations of Nucleus Accumbens Dynorphin Neurons Drive Aversion and Reward , 2015, Neuron.
[128] Wendy M. Knowlton,et al. Identification of Spinal Circuits Transmitting and Gating Mechanical Pain , 2014, Cell.
[129] Marc Parmentier,et al. Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor , 1995, Nature.
[130] G. Piñeyro,et al. Kir3 channel signaling complexes: focus on opioid receptor signaling , 2014, Front. Cell. Neurosci..
[131] L. Bohn,et al. Bias Factor and Therapeutic Window Correlate to Predict Safer Opioid Analgesics , 2017, Cell.
[132] J. Traynor,et al. Opioid receptor interacting proteins and the control of opioid signaling. , 2014, Current pharmaceutical design.
[133] R. Palmiter,et al. Activation of the kappa opioid receptor in the dorsal raphe nucleus mediates the aversive effects of stress and reinstates drug seeking , 2009, Proceedings of the National Academy of Sciences.
[134] E. Stuenkel,et al. κ-Opioid Receptor Activation Modulates Ca2+Currents and Secretion in Isolated Neuroendocrine Nerve Terminals , 1997, The Journal of Neuroscience.
[135] J. Levine,et al. Shared Mechanisms for Opioid Tolerance and a Transition to Chronic Pain , 2010, The Journal of Neuroscience.
[136] A. Light,et al. Hyperpolarization of substantia gelatinosa neurons evoked by μ-, κ-, δ1-, and δ2-selective opioids , 2002 .
[137] D. Filliol,et al. Quantitative autoradiographic mapping of opioid receptors in the brain of δ-opioid receptor gene knockout mice , 2002, Brain Research.
[138] S. Snyder,et al. Guanine nucleotides differentiate agonist and antagonist interactions with opiate receptors. , 1978, Life sciences.
[139] J. Sandkühler,et al. Induction of Synaptic Long-Term Potentiation After Opioid Withdrawal , 2009, Science.
[140] R. Kandasamy,et al. The pharmacology of nociceptor priming. , 2015, Handbook of experimental pharmacology.
[141] M. Low,et al. Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus , 2001, Nature.
[142] M. Morgan,et al. Evidence for an intrinsic mechanism of antinociceptive tolerance within the ventrolateral periaqueductal gray of rats , 2005, Neuroscience.
[143] L. Hood,et al. Dynorphin-(1-13), an extraordinarily potent opioid peptide. , 1979, Proceedings of the National Academy of Sciences of the United States of America.
[144] A. Basbaum,et al. Dissociation of the Opioid Receptor Mechanisms that Control Mechanical and Heat Pain , 2009, Cell.
[145] G. Pasternak. Mu Opioid Pharmacology: 40 Years to the Promised Land. , 2018, Advances in pharmacology.
[146] M. Bruchas,et al. Stress-Induced Reinstatement of Nicotine Preference Requires Dynorphin/Kappa Opioid Activity in the Basolateral Amygdala , 2016, The Journal of Neuroscience.
[147] A. Basbaum,et al. Knockin mice expressing fluorescent delta-opioid receptors uncover G protein-coupled receptor dynamics in vivo. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[148] Jürgen Sandkühler,et al. Long-term potentiation in spinal nociceptive pathways as a novel target for pain therapy , 2011, Molecular pain.
[149] D. Storm,et al. Constitutive μ-Opioid Receptor Activity Leads to Long-Term Endogenous Analgesia and Dependence , 2013, Science.
[150] Terence D Sanger. Basic and Translational Neuroscience of Childhood-Onset Dystonia: A Control-Theory Perspective. , 2018, Annual review of neuroscience.
[151] C. Chavkin,et al. Mu Opioid Receptor Activation of ERK1/2 Is GRK3 and Arrestin Dependent in Striatal Neurons* , 2006, Journal of Biological Chemistry.
[152] Benedikt Zott,et al. What Happens with the Circuit in Alzheimer's Disease in Mice and Humans? , 2018, Annual review of neuroscience.
[153] H. Pan,et al. Opioid-Induced Long-Term Potentiation in the Spinal Cord Is a Presynaptic Event , 2010, The Journal of Neuroscience.
[154] K. Palczewski,et al. Designing Safer Analgesics via μ-Opioid Receptor Pathways. , 2017, Trends in pharmacological sciences.
[155] A mu–delta opioid receptor brain atlas reveals neuronal co-occurrence in subcortical networks , 2014, Brain Structure and Function.
[156] Zhen-Zhong Xu,et al. β-arrestin-2 regulates NMDA receptor function in spinal lamina II neurons and duration of persistent pain , 2016, Nature Communications.
[157] T. Prisinzano,et al. Kappa opioids and the modulation of pain , 2010, Psychopharmacology.
[158] B. Schmidt,et al. Structural and functional interactions between six-transmembrane μ-opioid receptors and β2-adrenoreceptors modulate opioid signaling , 2015, Scientific Reports.
[159] H. Sakamoto,et al. MOR‐1‐immunoreactive neurons in the dorsal horn of the rat spinal cord: evidence for nonsynaptic innervation by substance P‐containing primary afferents and for selective activation by noxious thermal stimuli , 2002, The European journal of neuroscience.
[160] M. Bruchas,et al. The dynorphin/kappa opioid system as a modulator of stress-induced and pro-addictive behaviors , 2010, Brain Research.
[161] M. Bruchas,et al. Inflammatory Pain Promotes Increased Opioid Self-Administration: Role of Dysregulated Ventral Tegmental Area μ Opioid Receptors , 2015, The Journal of Neuroscience.
[162] H. Fields,et al. Opioid peptides (DAGO-enkephalin, dynorphin A(1–13), BAM 22P) microinjected into the rat brainstem: comparison of their antinociceptive effect and their effect on neuronal firing in the rostral ventromedial medulla , 1989, Brain Research.
[163] M. Angst,et al. Opioid-induced Hyperalgesia in Humans: Molecular Mechanisms and Clinical Considerations , 2008, The Clinical journal of pain.
[164] Nicole A. Crowley,et al. Dynorphin Controls the Gain of an Amygdalar Anxiety Circuit. , 2016, Cell reports.
[165] M. Morgan,et al. Antinociceptive tolerance revealed by cumulative intracranial microinjections of morphine into the periaqueductal gray in the rat , 2006, Pharmacology Biochemistry and Behavior.
[166] L. Devi,et al. Heteromers of μ‐δ opioid receptors: new pharmacology and novel therapeutic possibilities , 2015, British journal of pharmacology.
[167] B. Kieffer,et al. Opioid receptors: From binding sites to visible molecules in vivo , 2009, Neuropharmacology.
[168] G. Stuber,et al. Locus coeruleus to basolateral amygdala noradrenergic projections promote anxiety-like behavior , 2017, eLife.
[169] M. Narita,et al. Direct Evidence for the Involvement of the Mesolimbic κ-Opioid System in the Morphine-Induced Rewarding Effect Under an Inflammatory Pain-Like State , 2005, Neuropsychopharmacology.
[170] L. Gendron,et al. Recent advances on the δ opioid receptor: from trafficking to function , 2015, British journal of pharmacology.
[171] H. Ueda. Molecular mechanisms of neuropathic pain-phenotypic switch and initiation mechanisms. , 2006, Pharmacology & therapeutics.
[172] Bernardo L. Sabatini,et al. Photoactivatable Neuropeptides for Spatiotemporally Precise Delivery of Opioids in Neural Tissue , 2012, Neuron.
[173] E. E. Bagley,et al. β‐Arrestin‐2 knockout prevents development of cellular μ‐opioid receptor tolerance but does not affect opioid‐withdrawal‐related adaptations in single PAG neurons , 2015, British journal of pharmacology.
[174] T. Hales,et al. β-Arrestin2 and c-Src Regulate the Constitutive Activity and Recycling of μ Opioid Receptors in Dorsal Root Ganglion Neurons , 2007, The Journal of Neuroscience.
[175] H. Pan,et al. Removing TRPV1-expressing primary afferent neurons potentiates the spinal analgesic effect of δ-opioid agonists on mechano-nociception , 2008, Neuropharmacology.
[176] A. Duggan. Neuropeptide spread in the brain and spinal cord. , 2000, Progress in brain research.
[177] L. Becerra,et al. fMRI measurement of CNS responses to naloxone infusion and subsequent mild noxious thermal stimuli in healthy volunteers. , 2004, Journal of neurophysiology.
[178] J. Levine,et al. Contribution of supraspinal μ- and δ-opioid receptors to antinociception in the rat , 1991 .
[179] Aashish Manglik,et al. Structure of the δ-opioid receptor bound to naltrindole , 2012, Nature.
[180] Ian R. Wickersham,et al. A Circuit Mechanism for Differentiating Positive and Negative Associations , 2015, Nature.
[181] M. von Zastrow,et al. β-arrestin drives MAP kinase signaling from clathrin-coated structures after GPCR dissociation , 2016, Nature Cell Biology.
[182] R. Neve,et al. Suppression of RGSz1 function optimizes the actions of opioid analgesics by mechanisms that involve the Wnt/β-catenin pathway , 2018, Proceedings of the National Academy of Sciences.
[183] M. Bruchas,et al. Optogenetic approaches for dissecting neuromodulation and GPCR signaling in neural circuits. , 2017, Current opinion in pharmacology.
[184] A I Basbaum,et al. Endogenous pain control systems: brainstem spinal pathways and endorphin circuitry. , 1984, Annual review of neuroscience.
[185] C. Chavkin,et al. Preparation of brain membranes containing a single type of opioid receptor highly selective for dynorphin. , 1982, Proceedings of the National Academy of Sciences of the United States of America.
[186] M. E. Lewis,et al. Anatomy of CNS opioid receptors , 1988, Trends in Neurosciences.